Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Neoplastic Cells, Circulating 1

Interventions

cabazitaxel 3Trastuzumab 3Cyclophosphamide 2Cetuximab 2Carboplatin 2Aspirin 2ribociclib 1pertuzumab 1eribulin 1Thiotepa 1Taxes 1Stem Cell Transplantation 1Propofol 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Neoadjuvant Therapy 1Liquid Biopsy 1Letrozole 1Ipilimumab 1Histamine H2 Antagonists 1Histamine Antagonists 1Gemcitabine 1Fulvestrant 1Epirubicin 1Docetaxel 1Denosumab 1Circulating Tumor DNA 1Cell-Free Nucleic Acids 1CA-72-4 antigen 1CA-19-9 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neoplastic Cells, Circulating × CA-19-9 Antigen × Clear all
NCT03957564 2020-01-22

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

Affiliated Hospital of Qinghai University

Phase 2 Unknown
40 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡